Education
About Us
Working with TipRanks
Follow Us
Cecilia Daun Wennborg Insider Profile
4 Followers
Cecilia Daun Wennborg, Director at Oncopeptides AB, holds 70.82K shares in Oncopeptides AB (Ticker: SE:ONCO).
Cecilia Daun Wennborg Oncopeptides AB (ONCO)Director
Oncopeptides AB (ONCO)
Director
Ranked #37,073 out of 100,956 Corporate Insiders
Profitable Transactions
1 out of 3 Profitable Transactions
Average Return
+8.90%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Cecilia Daun Wennborg's holdings
Insider Roles
Director
Roles that Cecilia Daun Wennborg holds in companies
Most Profitable Insider Trade
The most profitable trade made by Cecilia Daun Wennborg
Cecilia Daun Wennborg's Trading History
List of latest transactions for each holding click on a transaction to see Cecilia Daun Wennborg's performance on stock
You May Also Like
Cecilia Daun Wennborg insider profile FAQ
What is the percentage of profitable transactions made by Cecilia Daun Wennborg?
The percentage of profitable transactions made by Cecilia Daun Wennborg is 33%.
What is the average return per transaction made by Cecilia Daun Wennborg?
The average return per transaction made by Cecilia Daun Wennborg is 8.90%.
What stocks does Cecilia Daun Wennborg hold?
Cecilia Daun Wennborg holds: SE:ONCO stocks.
What was Cecilia Daun Wennborg’s latest transaction?
Cecilia Daun Wennborg latest transaction was an Uninformative Buy of ―.
What was Cecilia Daun Wennborg's most profitable transaction?
Cecilia Daun Wennborg’s most profitable transaction was an Informative Buy of SE:ONCO stock on February 24, 2017. The return on the trade was 80.50%.
What is Cecilia Daun Wennborg's role in Oncopeptides AB?
Cecilia Daun Wennborg's role in Oncopeptides AB is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.